Xbrane Biopharma AB (XBRANE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The companys product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combines its proprietary microsphere and protein production technology platforms to develop and produce generics drugs for controlled release of the active substance through encapsulation in microspheres. The companys products find application in treating diseases across various therapeutic areas including acromegaly and neuroendocrine tumours, prostate cancer, endometriosis and uterine fibroids; age-related macular degeneration and macular oedema, among others. Xbrane is headquartered in Stockholm, Sweden.

Xbrane Biopharma AB (XBRANE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xbrane Biopharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Xbrane Biopharma to Enter into Distribution Agreement for Spherotide in China 10
XBrane Biopharma Enters into Distribution Agreement with Helvetic BioPharma for Xlucane 11
Xbrane Bioscience Enters into Distribution Agreement with Pooyesh Darou Pharma 12
Licensing Agreements 13
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 13
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 14
BioAvenir Enters into Licensing Agreement with Xbrane Biopharma 15
Equity Offering 16
Xbrane Biopharma Raises USD2.3 Million in Private Placement of Shares 16
Xbrane Biopharma Raises USD11.6 Million in Rights Offering of Shares 18
Acquisition 19
Xbrane Bioscience Acquires Primm Pharma 19
Xbrane Biopharma AB - Key Competitors 20
Xbrane Biopharma AB - Key Employees 21
Xbrane Biopharma AB - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 14, 2018: Xbrane Biopharma Releases Interim Report for the First Quarter of 2018 23
Feb 28, 2018: Xbrane Biopharma releases year-end report for 2017 24
Nov 13, 2017: Xbrane Biopharma releases interim report for the period July to September 2017 25
Aug 31, 2017: Xbrane Biopharma Releases Interim Report for the Period April June 2017 26
May 18, 2017: Xbrane Biopharma releases interim report for the period January - March 2017 27
Feb 27, 2017: Xbrane Biopharma releases 2016 Year End Report 28
Corporate Communications 29
Dec 13, 2017: Xbrane Biopharma informs about changes in management team 29
May 04, 2017: Xbrane Biopharma recruits CFO and Head of Investor Relations 30
Product News 31
Apr 11, 2017: Xbrane Biopharma Reports Positive In-vivo Efficacy Data On Spherotide 31
Mar 27, 2017: Xbrane Biopharma Delivers First Batch Of Spherotide To A Value Of 7 Msek 32
Other Significant Developments 33
May 24, 2018: Announcement from Xbrane Biopharmas annual general meeting 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables

List of Tables
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xbrane Biopharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xbrane Biopharma AB, Deals By Therapy Area, 2012 to YTD 2018 8
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Xbrane Biopharma to Enter into Distribution Agreement for Spherotide in China 10
XBrane Biopharma Enters into Distribution Agreement with Helvetic BioPharma for Xlucane 11
Xbrane Bioscience Enters into Distribution Agreement with Pooyesh Darou Pharma 12
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 13
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 14
BioAvenir Enters into Licensing Agreement with Xbrane Biopharma 15
Xbrane Biopharma Raises USD2.3 Million in Private Placement of Shares 16
Xbrane Biopharma Raises USD11.6 Million in Rights Offering of Shares 18
Xbrane Bioscience Acquires Primm Pharma 19
Xbrane Biopharma AB, Key Competitors 20
Xbrane Biopharma AB, Key Employees 21
Xbrane Biopharma AB, Subsidiaries 22

List Of Figures

List of Figures
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xbrane Biopharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Xbrane Biopharma AB (XBRANE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The companys product portfolio includes biosimilars and long acting injectables developed

USD 250 View Report

Xbrane Biopharma AB Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Xbrane Biopharma AB Company Profile is a detailed strategic and analytical report on Xbrane Biopharma AB. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Hansa Biopharma AB (HNSA) - Financial and Strategic SWOT Analysis Review

Hansa Biopharma AB (HNSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Xbrane Biopharma AB Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Xbrane Biopharma AB Company Profile is a detailed strategic and analytical report on Xbrane Biopharma AB. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available